Hoth Therapeutics, Inc. (HOTH)

Hoth Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.01	7.04	9.29	6.43	8.54	2.63
Short-Term Investments	-	-	-	0.21	1.89	2.06
Cash & Short-Term Investments	9.01	7.04	9.29	6.64	10.43	4.69
Cash Growth	-6.64%	-24.25%	39.99%	-36.36%	122.27%	88.13%
Other Receivables	0.05	0.05	0.05	-	-	-
Receivables	0.05	0.05	0.05	-	0.05	-
Prepaid Expenses	0.99	0.56	0.81	0.09	0.09	0.09
Total Current Assets	10.05	7.64	10.15	6.73	10.58	4.78
Property, Plant & Equipment	0.02	0.03	0.06	-	-	-
Long-Term Investments	0.04	0.04	0.04	0.03	0.41	0.41
Total Assets	10.11	7.71	10.24	6.76	10.99	5.24
Accounts Payable	0.08	0.41	0.04	0.69	0.36	0.13
Accrued Expenses	0.27	0.39	0.61	0.69	0.51	0.18
Current Portion of Leases	0.02	0.03	0.03	-	-	-
Total Current Liabilities	0.36	0.83	0.68	1.39	0.87	0.31
Long-Term Leases	-	0	0.03	-	-	-
Other Long-Term Liabilities	-	-	-	0.25	0.24	0.29
Total Liabilities	0.36	0.83	0.7	1.64	1.1	0.6
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	75.82	67.28	61.73	50.2	43.59	24.07
Retained Earnings	-66.09	-60.41	-52.22	-45.1	-33.73	-19.41
Comprehensive Income & Other	0.01	0.01	0.03	0.02	0.02	-0.02
Total Common Equity	9.74	6.88	9.54	5.12	9.88	4.65
Shareholders' Equity	9.74	6.88	9.54	5.12	9.88	4.65
Total Liabilities & Equity	10.11	7.71	10.24	6.76	10.99	5.24
Total Debt	0.02	0.03	0.06	-	-	-
Net Cash (Debt)	8.99	7.01	9.24	6.64	10.43	4.69
Net Cash Growth	-6.46%	-24.13%	39.16%	-36.36%	122.27%	88.13%
Net Cash Per Share	0.90	1.10	2.71	5.54	11.68	9.49
Filing Date Shares Outstanding	13.26	13.17	4.4	3.3	0.96	0.91
Total Common Shares Outstanding	13.23	8.04	4.35	1.3	0.96	0.54
Working Capital	9.69	6.81	9.47	5.34	9.71	4.47
Book Value Per Share	0.74	0.86	2.19	3.93	10.30	8.64
Tangible Book Value	9.74	6.88	9.54	5.12	9.88	4.65
Tangible Book Value Per Share	0.74	0.86	2.19	3.93	10.30	8.64

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q